Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the acf domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /home/cr0ph/staging.phastar.com/wp-includes/functions.php on line 6260
Building Effective Biotech and CRO Partnerships | Phastar
Handshake formed from glowing digital particles

Building Effective Partnerships Between Biotechs and CROs to Advance Clinical Development 

1 minute read

Published: July 21st, 2026

The biotech industry is evolving rapidly, with emerging companies leading the charge in clinical development. As outsourcing to CROs (Contract Research Organizations) grows, choosing the right partner is more critical than ever. This comprehensive white paper provides actionable insights and top tips for biotech companies navigating the vendor selection process. 

What you’ll learn:

  • The key challenges facing biotechs in the current clinical trial landscape.
  • Common pitfalls in outsourcing and how to avoid them.
  • How strategic partnerships with CROs can drive efficiency and innovation.
  • A case study showcasing how significant savings can be made through effective CRO collaboration.
  • Four essential tips for selecting the right vendor to support your clinical trials.

Gain access to expert advice and practical strategies that can help your biotech company make informed decisions, avoid costly mistakes, and build successful partnerships that accelerate clinical development.

Ready to elevate your clinical strategy?  

Fill in your details to download the white paper now!

Related articles

Transforming Clinical Development Through Exploration, Automation, and Prediction with AI

Transforming Clinical Development Through Exploration, Automation, and Prediction with AI

September 23rd, 2026 1 minute read

Artificial intelligence is transforming how life sciences organizations generate evidence, design clinical trials, an...

Flexible Dose-Finding in Early-Phase Oncology Combination Studies Enabling Mid-Trial Dose Insertions to Improve Dose Recommendations

Flexible Dose-Finding in Early-Phase Oncology Combination Studies Enabling Mid-Trial Dose Insertions to Improve Dose Recommendations

April 2nd, 2026 1 minute read

Early-phase oncology combination trials often assume the optimal dose is already included in the dosing gri...

Leveraging Real-World Data for in-silico Trials: Enhancing Clinical Development and Regulatory Confidence

Leveraging Real-World Data for in-silico Trials: Enhancing Clinical Development and Regulatory Confidence

December 3rd, 2025 1 minute read

As the pharmaceutical landscape evolves, traditional clinical trial designs are increasingly complemented by innovati...